Nephros (NEPH) Gross Margin (2010 - 2026)

Nephros' Gross Margin history runs 17 years deep, the most recent figure standing at 57.43% for Q1 2026.

• In Q1 2026, Gross Margin fell 725.0% year-over-year to 57.43%; the TTM figure through Mar 2026 stood at 59.95% (down 250.0% YoY), while the FY2025 annual figure was 61.87%, up 28.0% from the prior year.
• Gross Margin was 57.43% for Q1 2026 at Nephros, down from 58.38% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 64.67% in Q1 2025 to a low of 31.63% in Q3 2022.
• Historically, Gross Margin has averaged 57.39% across 5 years, with a median of 58.79% in 2024.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 2112 bps in 2022, then soared 2700 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 58.99% in 2022, then rose by 5 bps to 62.11% in 2023, then increased by 3 bps to 63.95% in 2024, then retreated by 9 bps to 58.38% in 2025, then decreased by 2 bps to 57.43% in 2026.
• The last three Gross Margin figures came in at 57.43% (Q1 2026), 58.38% (Q4 2025), and 61.19% (Q3 2025), per Business Quant data.